For laboratory research use only. Not for human or veterinary use.

Same-day dispatch on orders before 4 PM ET · Support

L-Glutathione: discovery, structure and research history

Research Library › Mitochondrial & Coenzyme

Glutathione (GSH) is a tripeptide of glutamic acid, cysteine and glycine that cells make for themselves and use in oxidation-reduction chemistry. Cambridge biochemist Frederick Gowland Hopkins isolated and named it in 1921, and its tripeptide structure was settled in 1929. As of 22 Oct 2026 it has no verified FDA drug approval and is listed by FDA as under evaluation for pharmacy compounding.

Key facts

TypeEndogenous tripeptide (three amino acids)
Structuregamma-L-glutamyl-L-cysteinylglycine (Glu-Cys-Gly)
First described1921, Hopkins, Biochemical Journal
Discovered byFrederick Gowland Hopkins (Cambridge); structure confirmed independently by Edward C. Kendall's team
Natural roleIntracellular thiol involved in redox reactions throughout the body
Regulatory status (Oct 2026)No verified FDA drug approval; under FDA evaluation for 503A compounding

Who discovered it

Frederick Gowland Hopkins, a biochemist at the University of Cambridge, isolated a sulfur-containing substance from living tissue in 1921 and named it glutathione [1, 2]. He was studying oxidation inside cells and found the compound widespread in actively multiplying plant and animal cells [2, 3].

Hopkins received the 1929 Nobel Prize in Physiology or Medicine, though for his discovery of growth-stimulating vitamins, not for glutathione [4]. Edward Calvin Kendall, whose team confirmed the final structure, later shared the 1950 Nobel Prize in Physiology or Medicine for work on adrenal cortex hormones.

Structure and natural role

Hopkins first reported glutathione as a dipeptide of glutamic acid and cysteine. The structure was disputed for several years until 1929, when Hopkins published a reinvestigation and Edward Calvin Kendall’s group at the Mayo Clinic independently reached the same conclusion: it is a tripeptide of glutamic acid, cysteine and glycine [1, 5, 6]. Unusually, the glutamic acid is linked through its side-chain (gamma) carboxyl group rather than the standard peptide bond [7].

Cells build glutathione in two enzymatic steps. Its cysteine thiol group lets it cycle between a reduced form (GSH) and an oxidized, paired form (GSSG), and an enzyme recycles the oxidized form. Researchers use the ratio of the two forms as a laboratory marker of oxidative stress [7].

Why it was studied

Glutathione was discovered through basic chemistry rather than drug development. Hopkins wanted to understand how living cells carry out oxidation, and glutathione became one of the first small molecules shown to take part in that process [2, 3]. It remains a standard subject of biochemistry research, and measurements of reduced and oxidized glutathione are routine tools in cell-biology laboratories. Because it is made by the body, glutathione is classed as an endogenous peptide rather than a designed drug molecule.

Research timeline

  • 1921: Hopkins isolates and names glutathione [1, 2]
  • 1929: Hopkins and Kendall’s team independently establish the tripeptide structure [5, 6]
  • 1929: Hopkins shares the Nobel Prize in Physiology or Medicine, for vitamin research [4]
  • May 2026: FDA lists glutathione as under evaluation for 503A compounding [8]

Regulatory status as of October 2026

As of 22 Oct 2026, no FDA drug approval for glutathione has been verified. Glutathione has been nominated for use in 503A pharmacy compounding; on FDA’s nominated-substances list updated 14 May 2026 it appears in Category 1, the group of nominated substances still under evaluation, with no final decision [8]. Category 1 placement is an interim status and does not amount to an approval or an FDA safety finding.

Glutathione is distinct from its precursor amino acids and from N-acetylcysteine (NAC), a separate cysteine derivative with its own regulatory history.

Glutathione is not named on the World Anti-Doping Agency’s 2026 Prohibited List [9].

Available from Kalibra Labs

Supplied as a lyophilized research material with a Certificate of Analysis matched to each lot number.

Look up a Certificate of Analysis by lot number →

Frequently asked questions

Who discovered glutathione?

Frederick Gowland Hopkins of the University of Cambridge isolated and named glutathione in 1921.

Is glutathione a peptide?

Yes. Glutathione is a tripeptide made of glutamic acid, cysteine and glycine, with an unusual gamma linkage between the first two.

Is glutathione FDA approved?

No FDA drug approval has been verified. As of October 2026, FDA lists glutathione as under evaluation for pharmacy compounding.

What is the difference between GSH and GSSG?

GSH is reduced glutathione; GSSG is the oxidized form, in which two glutathione molecules are joined by a disulfide bond.

What does the L in L-glutathione mean?

The L refers to the natural stereochemistry of its amino acids; L-glutathione is the form cells produce.

Sources

  1. Hopkins FG. On an autoxidisable constituent of the cell. Biochem J. 1921;15(2):286-305. doi:10.1042/bj0150286. Link
  2. NobelPrize.org. Sir Frederick Hopkins: biographical. Link
  3. Wikipedia. Frederick Gowland Hopkins (citing Hopkins FG, J Biol Chem 1929;84:269-320, and Kendall EC et al., J Biol Chem 1929;84:657-674). Link
  4. NobelPrize.org. Sir Frederick Hopkins: facts (Nobel Prize in Physiology or Medicine 1929, "for his discovery of the growth-stimulating vitamins"). Link
  5. Hopkins FG. On glutathione: a reinvestigation. J Biol Chem. 1929;84(1):269-320. doi:10.1016/S0021-9258(18)77062-2. Link
  6. Kendall EC, McKenzie BF, Mason HL. A study of glutathione. J Biol Chem. 1929;84(2):657-674. Link
  7. Wikipedia. Glutathione (structure, synthesis, redox role). Link
  8. FDA. Bulk drug substances nominated for use in compounding under section 503A (Categories 1-3). Updated 14 May 2026. Link
  9. World Anti-Doping Agency. 2026 Prohibited List. Link

Regulatory information current as of October 2026. Reviewed by the Kalibra Labs editorial team.

For Research Use Only. Kalibra Labs supplies this compound as a lyophilized research material for in-vitro laboratory use. It is not for human or veterinary use and not for use in diagnostic or therapeutic procedures. This page is a scientific and historical reference; it is not medical advice and makes no claim about use in people or animals.

0
Your Cart
Empty CartYour cart is emptyReturn to Shop
Scroll to Top